Search for content and authors |
Synthesis and evaluation of inhibitory activity of novel C-5 substituted uridine derivatives |
Jadwiga Paszkowska , Ilona Wandzik , Tadeusz Bieg |
Silesian University of Technology, Department of Organic Chem., Bioorganic Chem. and Biotechnol., Krzywoustego 4, Gliwice 44-100, Poland |
Abstract |
The biosynthesis of polysaccharides and glycoconjugates mediated by glycosyltransferases (GTs) has attracted increasing interest. Modulation of GTs activity by selective inhibitors has become a tool for investiagation of biochemical pathways and also a new field for a novel therapeutics discovery. The natural donor substrates for the majority of glycosyltransferases are UDP-sugars. They are bound to the active site of enzyme by coordination to divalent metal ion through diphosphate group. The aim of this work was to synthesize potential β-1,4-galactosyltransefrase inhibitors that are analogues of natural donor substrate (UDP-Gal). A variety of pyrophosphate analogues that can mimic pyrophosphate-metal interactions have been developed[1-6]. We decided to replace the diphosphate unit with β-ketoenol group which is known to coordinate to divalent metal ion. The designed compounds were composed of uridine unit connected to substituted aromatic ring through different linkages. Structures of all final products were confirmed by 1H and 13C NMR spectroscopy. All synthesized compounds were tested as potential inhibitors in a competition assay against bovine milk β-1,4-galactosyltransferase. We have applied the fluorescence assay developed by Praly and co-workers to measure GTs activity[4]. This method utilizes fluorescent-labeled acceptor β-GlcNAc-O-(CH2)6-dansyl instead of the natural substrate. The samples were analyzed using reversed-phase HPLC with fluorescent detector. Synthesis of target compounds and evaluation of their activity will be presented. Acknowledgement Research studies part-financed by European Union within the European Regional Development Fund (POIG 01.01.02-14-102/09) References [1] K.-H. Jung, R.R. Schmidt, Glycosyltransferase Inhibitors in Carbohydrate-Based Discovery (C.-H. Wong, Ed.), Wiley-VCH Verlag, Weinheim, 2003, 2, 609–659. [2] M.M. Vaghefi, R.J. Bernacki, W.J. Hennen, R.K. Robins, J. Med. Chem., 1987, 30, 1383–1391. [3] M.M. Vaghefi, R.J. Bernacki, W.J. Hennen, R.K. Robins, J. Med. Chem., 1987, 30, 1391–1399. [4] S. Vidal, I. Bruyere, A. Malleron, C. Augé, J.-P. Praly, Bioorg. Med. Chem., 2006, 14, 7293–7301 [5] R. Wang, D.H. Steensma, Y. Takaoka, J.W. Yun, T. Kajimoto, C-H. Wong, Bioorg. Med. Chem., 1997, 5, 661–672. [6] I. Wandzik, T. Bieg, M. Czaplicka, Bioorg. Chem., 2009, 37, 211-216. |
Legal notice |
|
Related papers |
Presentation: Poster at VIII Multidyscyplinarna Konferencja Nauki o Leku, by Jadwiga PaszkowskaSee On-line Journal of VIII Multidyscyplinarna Konferencja Nauki o Leku Submitted: 2012-03-15 15:26 Revised: 2012-03-15 15:33 |